Misdiagnosis of ARVC leading to inappropriate ICD implant and subsequent ICD removal - lessons learned.


Journal

Journal of cardiovascular electrophysiology
ISSN: 1540-8167
Titre abrégé: J Cardiovasc Electrophysiol
Pays: United States
ID NLM: 9010756

Informations de publication

Date de publication:
10 2019
Historique:
received: 28 05 2019
revised: 28 06 2019
accepted: 09 07 2019
pubmed: 26 7 2019
medline: 22 9 2020
entrez: 26 7 2019
Statut: ppublish

Résumé

Arrhythmogenic right ventricular cardiomyopathy (ARVC) is an inherited progressive cardiomyopathy characterized by frequent life-threatening arrhythmias. The diagnosis of ARVC is challenging and is on the basis of a set of major and minor criteria as described by the modified Task Force Criteria (TFC). We report our clinical experience in a series of patients who were misdiagnosed with ARVC and subsequently underwent removal of their implantable cardioverter defibrillator (ICD) after a re-evaluation at our center. We studied 12 patients who were misdiagnosed with ARVC and had ICD implantation before our assessment. All patients had a repeat evaluation and were scored according to TFC before ICD removal. Cardiac magnetic resonance imaging (CMR) studies performed at outside institutions during the initial evaluation were reported abnormal and classified as meeting major TFC in ninety percent of patients. The most common abnormality reported was fatty infiltration of the right ventricular (RV) free wall and/or presence of focal intra-myocardial fat in six patients (50%). On re-evaluation, none of these findings fulfilled the TFC for the diagnosis. This study demonstrated that high dependence on misinterpretation of CMR along with a misunderstanding of the TFC evaluation are the main reasons for the misdiagnosis of ARVC. Despite the updated criteria for almost a decade, this study reminds that the diagnosis of ARVC is complex and hence careful TFC evaluation and consideration of multiple cardiac test results should be the focused approach for clinicians when confronted with suspected ARVC patients.

Identifiants

pubmed: 31343808
doi: 10.1111/jce.14088
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2020-2026

Subventions

Organisme : Healing Hearts Foundation
Pays : International
Organisme : Fondation Leducq
Pays : International
Organisme : Francis P. Chiaramonte Private foundation
Pays : International
Organisme : Dr. Satish, Rupal and Robin Shah ARVD fund at Johns Hopkins
Pays : International
Organisme : Peter French Memorial Foundation
Pays : International
Organisme : Wilmerding Endowments
Pays : International
Organisme : the Bogle Foundation
Pays : International
Organisme : Patrick J. Harrison Family
Pays : International
Organisme : Campanella Family
Pays : International
Organisme : Leyla Erkan family Fund for ARVD Research
Pays : International
Organisme : Leonie-Wild Foundation
Pays : International

Informations de copyright

© 2019 Wiley Periodicals, Inc.

Auteurs

Apurva Sharma (A)

Division of Cardiology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland.

Fabrizio Assis (F)

Division of Cardiology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland.

Cynthia A James (CA)

Division of Cardiology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland.

Brittney Murray (B)

Division of Cardiology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland.

Crystal Tichnell (C)

Division of Cardiology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland.

Harikrishna Tandri (H)

Division of Cardiology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland.

Hugh Calkins (H)

Division of Cardiology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH